Evonik is one of the world's leading specialty chemicals companies. Profitable growth and sustained value creation form the heart of our strategy. Around 80 percent of sales come from leading market positions, which we plan to expand further. We concentrate on high-growth megatrends, especially health, nutrition, resource efficiency and globalization.
For more than 50 years, Evonik EUDRAGIT® polymers have been controlling drug release from oral solid dosage forms. As coatings they direct the release of the active pharmaceutical ingredient, either in response to the pH value or time controlled, to the resorption area in the small intestine or to the colon. Furthermore they mask unpleasant tastes and odors and, if required, protect not only the active ingredient, but the stomach as well. The name EUDRAGIT® also stands for extensive service. With EUDRAGIT® polymers, Evonik develops, together with its customers, the optimal formulation for each active ingredient.
Rexim® stands for a wide range of amino acids, peptides, and amino acid derivatives available in pharma, food, and highpurity cGMP grades for a comprehensive technology base that encompasses biotechnology, enzyme catalysis, and chemical synthesis, as well as backward integration into amino acids. Rexim® therefore also means supply security and expertise in regulatory matters.
Complete la siguiente información para coordinar una cita en este stand durante el evento.